Skip to main content
. 2022 Jun 27;13:951831. doi: 10.3389/fphar.2022.951831

FIGURE 8.

FIGURE 8

Effect of the SNM on molecular-targeted drugs inhibiting the subcutaneous growth of human HCC cells in immunodeficient mice. MHCC97-H cells were obtained by culture, and inoculated subcutaneously in immunodeficient SCID mice. Then, mice were given sorafenib (0.5, 1, 3 mg/kg) alone or combined with the SNM (0.2 g/kg). Photographs of subcutaneous tumors (A), tumor volume (B), or tumor weight (C) are shown. *p < 0.05.